| REGISTERED NUMBER: |
| Financial Statements For The Year Ended 30 November 2024 |
| for |
| MacPharm Limited |
| REGISTERED NUMBER: |
| Financial Statements For The Year Ended 30 November 2024 |
| for |
| MacPharm Limited |
| MacPharm Limited (Registered number: SC190224) |
| Contents of the Financial Statements |
| For The Year Ended 30 November 2024 |
| Page |
| Company Information | 1 |
| Abridged Statement of Financial Position | 2 |
| Notes to the Financial Statements | 3 |
| MacPharm Limited |
| Company Information |
| For The Year Ended 30 November 2024 |
| DIRECTORS: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| INDEPENDENT AUDITORS: |
| Chartered Accountants & Statutory Auditors |
| Regent Court |
| 70 West Regent Street |
| Glasgow |
| G2 2QZ |
| MacPharm Limited (Registered number: SC190224) |
| Abridged Statement of Financial Position |
| 30 November 2024 |
| 2024 | 2023 |
| £ | £ |
| CURRENT ASSETS |
| Debtors |
| Cash at bank |
| CREDITORS |
| Amounts falling due within one year |
| NET CURRENT ASSETS |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| CAPITAL AND RESERVES |
| Called up share capital |
| SHAREHOLDERS' FUNDS |
| The financial statements were approved by the Board of Directors and authorised for issue on |
| MacPharm Limited (Registered number: SC190224) |
| Notes to the Financial Statements |
| For The Year Ended 30 November 2024 |
| 1. | STATUTORY INFORMATION |
| MacPharm Limited is a |
| The presentation currency of the financial statements is the Pound Sterling (£). |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| Related party exemption |
| The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group. |
| Financial instruments |
| Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss. |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date. |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| 3. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the year was NIL (2023 - NIL). |
| 4. | DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006 |
| The Report of the Auditors was unqualified. |
| for and on behalf of |
| MacPharm Limited (Registered number: SC190224) |
| Notes to the Financial Statements - continued |
| For The Year Ended 30 November 2024 |
| 5. | ULTIMATE PARENT COMPANY |
| GAM Stuart Ltd is regarded by the directors as being the company's ultimate parent company. |
| 6. | ULTIMATE CONTROLLING PARTY |
| The ultimate controlling parties are G A M Stuart and A S Bilon by virtue of their majority shareholding of GAM Stuart Ltd. |